肥厚型梗阻性心肌病合并阻塞型睡眠呼吸暂停的研究进展

周锐飞; 陈硕; 张文超; 董一飞

doi:10.13201/j.issn.1001-1439.2020.11.003

肥厚型梗阻性心肌病合并阻塞型睡眠呼吸暂停的研究进展

- 1 南昌大学第二附属医院心血管内科(南昌, 330006);
- 2 江西省分子医学重点实验室
基金项目:
江西省科学技术厅重点研发项目一般项目(No:20171BBG70088)

江西省“5511”科技创新人才项目(No:20165BCB18020)

国家自然科学基金(No:81960088)

详细信息

通讯作者: 董一飞,E-mail:yf_dong66@126.com

中图分类号: R542.2

收稿日期: 2020-05-28

Progress of hypertrophic obstructive cardiomyopathy with obstructive sleep apnea

- 1 Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, China;
- 2 Key Laboratory of Molecular Medicine of Jiangxi Province

More Information

Corresponding author: DONG Yifei, E-mail: yf_dong66@126.com

Received Date: 28 May 2020

摘要

摘要: 肥厚型心肌病(HCM)患者阻塞型睡眠呼吸暂停(OSA)的发生率较高。肥厚型梗阻性心肌病(HOCM)在HCM患者中约占2/3。OSA可以通过多种机制来增加HCM患者左室肥厚及加重左室流出道梗阻。本文就HOCM合并OSA患者的临床特征和最新研究进展作一综述。
- 肥厚型梗阻性心肌病 /
- 阻塞型睡眠呼吸暂停 /
- 持续气道正压通气
Abstract: The incidence of obstructive sleep apnea(OSA) is higher in patients with hypertrophic cardiomyopathy(HCM). Hypertrophic obstructive cardiomyopathy(HOCM) accounts for about 2/3 of HCM patients. OSA can increase left ventricular hypertrophy and aggravate left ventricular outflow tract obstruction in HCM patients through a variety of mechanisms. This article reviews the clinical characteristics and recent research progress of in HOCM patients with OSA.
- hypertrophic obstructive cardiomyopathy /
- obstructive sleep apnea /
- continuous positive airway pressure

HTML全文

参考文献(22)

[1]	Van Driest SL,Ommen SR,Tajik AJ,et al.Yield of genetic testing in hypertrophic cardiomyopathy[J].Mayo Clin Proc,2005,80(6):739-744.
[2]	Authors/Task Force members,Elliott PM,Anastasakis A,et al.2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy:the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology(ESC)[J].Eur Heart J,2014,35(39):2733-2779.
[3]	Semsarian C,Ingles J,Maron MS,et al.New perspectives on the prevalence of hypertrophic cardiomyopathy[J].J Am Coll Cardiol,2015,65(12):1249-1254.
[4]	邹玉宝,宋雷.2017中国成人肥厚型心肌病诊断与治疗指南精要解读[J].中国分子心脏病学杂志,2018,18(2):2396-2400.
[5]	Elliott PM,Gimeno JR,Tomé MT,et al.Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy[J].Eur Heart J,2006,27(16):1933-1941.
[6]	邓婷智,欧柏青,朱天刚,等.合并与未合并高血压的肥厚型心肌病的临床特点[J].临床心血管病杂志,2018,34(7):703-708.
[7]	范一宁,姜克新.超声心动图评价肥厚型心肌病患者升主动脉弹性的价值[J].临床心血管病杂志,2019,35(2):141-144.
[8]	Budhiraja R,Budhiraja P,Quan SF.Sleep-disordered breathing and cardiovascular disorders[J].Respir Care,2010,55(10):1322-1332.
[9]	杜国栋,吕云辉,雷强,等.CPAP治疗对阻塞性睡眠低通气综合征患者导管消融术后心房颤动复发率影响的Meta分析[J].临床心血管病杂志,2017,33(5):415-418.
[10]	Nerbass FB,Pedrosa RP,Danzi-Soares NJ,et al.Obstructive sleep apnea and hypertrophic cardiomyopathy:a common and potential harmful combination[J].Sleep Med Rev,2013,17(3):201-206.
[11]	Akita K,Maekawa Y,Kohno T,et al.Ameliorating the severity of sleep-disordered breathing concomitant with heart failure status after percutaneous transluminal septal myocardial ablation for drug-refractory hypertrophic obstructive cardiomyopathy[J].Heart Vessels,2017,32(11):1320-1326.
[12]	Jain R,Osranek M,Jan MF,et al.Marked respiratory-related fluctuations in left ventricular outflow tract gradients in hypertrophic obstructive cardiomyopathy:an observational study[J].Eur Heart J Cardiovasc Imaging,2018,19(10):1126-1133.
[13]	Wang S,Cui H,Song C,et al.Obstructive sleep apnea is associated with nonsustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy[J].Heart Rhythm,2019,16(5):694-701.
[14]	Wang S,Cui H,Zhu C,et al.Obstructive sleep apnea causes impairment of the carotid artery in patients with hypertrophic obstructive cardiomyopathy[J].Respir Med,2019,150:107-112.
[15]	Jalanko M,Tarkiainen M,Sipola P,et al.Left ventricular mechanical dispersion is associated with nonsustained ventricular tachycardia in hypertrophic cardiomyopathy[J].Ann Med,2016,48(6):417-427.
[16]	Dimitrow PP,Chojnowska L,Rudzinski T,et al.Sudden death in hypertrophic cardiomyopathy:old risk factors re-assessed in a new model of maximalized follow-up[J].Eur Heart J,2010,31(24):3084-3093.
[17]	Lopez-Jimenez F,Sert Kuniyoshi FH,Gami A,et al.Obstructive sleep apnea:implications for cardiac and vascular disease[J].Chest,2008,133(3):793-804.
[18]	Bradley TD,Hall MJ,Ando S,et al.Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure[J].Chest,2001,119(6):1827-1835.
[19]	Brinker JA,Weiss JL,Lappé DL,et al.Leftward septal displacement during right ventricular loading in man[J].Circulation,1980,61(3):626-633.
[20]	Sengupta PP,Sorajja D,Eleid MF,et al.Hypertrophic obstructive cardiomyopathy and sleep-disordered breathing:an unfavorable combination[J].Nat Clin Pract Cardiovasc Med,2009,6(1):14-15.
[21]	Banno K,Shiomi T,Sasanabe R,et al.Sleep-disordered breathing in patients with idiopathic cardiomyopathy[J].Circ J,2004,68(4):338-342.
[22]	Wang S,Cui H,Meng L,et al.Effect of septal myectomy on obstructive sleep apnoea syndrome in patients with hypertrophic obstructive cardiomyopathy[J].Heart Lung Circ,2020,29(9):1366-1374.